Dollar General Medicated Pain Relief Patch

Description

Dollar General Medicated Pain Relief Patch is designed for topical application. It is essential to store the patch in a clean, dry place, away from direct sunlight, and to protect it from excessive moisture to maintain its efficacy.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children 12 years of age and over should begin by cleaning and drying the affected area thoroughly. The patch should be removed from its protective film and applied directly to the affected area. It is recommended that the patch be applied no more than 3 to 4 times daily. Each patch should be removed from the skin after a maximum application duration of 8 hours.

For children under 12 years of age, it is advised to consult a physician prior to use to determine appropriate treatment options and dosages.

Contraindications

Use of this product is contraindicated in individuals with a known allergy to any of its ingredients.

Application on wounds or damaged skin is prohibited due to the potential for adverse reactions. The use of a heating pad concurrently with this product is also contraindicated, as it may increase the risk of skin irritation or burns.

Additionally, contact with eyes, mucous membranes, or rashes should be avoided to prevent irritation. Tight bandaging is not recommended, and concurrent use with other topical analgesics is contraindicated to avoid compounded effects and potential toxicity.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to consult a doctor prior to use if they have a history of allergic reactions to aspirin or salicylates.

It is imperative to exercise caution when using this product. The application should be avoided on wounds or damaged skin, and it should not be used in conjunction with a heating pad. Additionally, individuals with known allergies to any of the product's ingredients should refrain from use.

Patients should be instructed to discontinue use and seek medical attention if they experience any of the following: rash, itching, or excessive skin irritation; worsening of their condition; or if symptoms persist beyond 7 days or resolve only to recur within a few days.

In the event of accidental ingestion, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay.

Side Effects

Patients should be aware of potential adverse reactions associated with the use of this medication. Individuals with a known allergy to aspirin or salicylates are advised to consult a healthcare professional prior to use to mitigate the risk of an allergic reaction.

In the event that patients experience a rash, itching, or excessive skin irritation, it is recommended that they discontinue use and seek medical advice. Additionally, if the condition worsens or if symptoms persist beyond 7 days, or if symptoms resolve only to recur within a few days, patients should also consult a doctor. These precautions are essential to ensure patient safety and effective management of any adverse effects that may arise during treatment.

Drug Interactions

Concurrent use of this medication with other topical analgesics is contraindicated. The combination may increase the risk of adverse effects without providing additional therapeutic benefit. It is advised to avoid using multiple topical analgesics simultaneously to ensure patient safety and optimal therapeutic outcomes. Monitoring for any signs of increased local irritation or systemic effects is recommended if there is a concern about inadvertent overlap in therapy.

Packaging & NDC

Below are the non-prescription pack sizes of Dollar General Medicated Pain Relief Patch (camphor, menthol, methyl salicylate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a physician prior to use. It is essential to keep the product out of reach of children, as used patches still contain the drug and can pose serious risks if chewed or ingested by children or pets. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is advised.

For patients aged 12 years and older, the recommended application involves cleaning and drying the affected area before applying the patch. The patch should be removed from its film and applied to the affected area no more than 3 to 4 times daily, with a maximum application duration of 8 hours. Proper disposal of used patches is crucial to prevent accidental exposure to children and pets.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

The safety of this product during pregnancy has not been established. Pregnant patients or those planning to become pregnant should consult a healthcare provider before use. Potential risks to the fetus are not clearly defined; therefore, caution is advised. There are no specific dosage modifications for pregnant individuals. This product should be used only if clearly needed and after a thorough discussion with a healthcare provider regarding the potential risks and benefits.

Lactation

There are no specific warnings or recommendations regarding the use of this product by nursing mothers. Additionally, there is no information provided regarding the potential for excretion in breast milk or any associated risks to breastfed infants during lactation.

Renal Impairment

There is no information available regarding renal impairment, including dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of specific guidance when treating patients with renal impairment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the lack of detailed overdosage data necessitates a vigilant approach. Symptoms may vary depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement standard supportive measures, which may include maintaining airway patency, providing supplemental oxygen, and ensuring adequate circulation.

Additionally, it is recommended to contact a poison control center or consult relevant toxicology resources for guidance on specific management strategies tailored to the situation. Continuous assessment and supportive care are critical in managing any adverse effects that may occur due to overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to instruct patients not to apply the product on wounds or damaged skin, and to avoid using it in conjunction with a heating pad.

Patients should be informed of the potential for allergic reactions and advised not to use the product if they are allergic to any of its ingredients. They should be instructed to discontinue use and consult a doctor if they experience rash, itching, or excessive skin irritation. Additionally, patients should be made aware that they should stop using the product and seek medical advice if their condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days.

Providers should emphasize the importance of using the product only as directed and advise patients to avoid contact with eyes, mucous membranes, or rashes. It is also crucial to inform patients not to bandage the area tightly and to refrain from using the product simultaneously with other topical analgesics.

Finally, healthcare providers should counsel patients on the safe disposal of used patches, ensuring that they are kept out of reach of children and pets, as used patches still contain the drug product, which can lead to serious adverse effects if ingested.

Storage and Handling

The product is available in various package configurations, with specific NDC numbers assigned for identification. Storage and handling instructions are not explicitly provided; therefore, standard practices for pharmaceutical products should be followed. It is advisable to store the product in a controlled environment, ensuring that it is kept at appropriate temperatures to maintain its integrity and efficacy. Containers should be secure and suitable for the product type to prevent contamination or degradation. Special handling requirements are not specified, but general precautions should be taken to ensure the product remains in optimal condition during storage and transport.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Dollar General Medicated Pain Relief Patch, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)